ABOUT US - Lo.Li. Pharma International

WE

ARE

LO.LI. PHARMA

INTERNATIONAL

Since Lo.Li. Pharma’s establishment in 2001, the Group — including Lo.Li. Pharma International — has been at the forefront of healthcare innovation. Our journey is a testament to our unwavering commitment to advancing global health through pioneering pharmaceutical solutions

OUR STORY

The Lo.Li. Pharma Group was originally founded to fill therapeutic gaps, which were identified in the clinic by our founder, Professor Vittorio Unfer, MD.

Based in Rome, our company excels in distributing medical devices and food supplements internationally. Specialized in out-licensing, we ensure global access to our parent company’s advanced formulations and scientific breakthroughs.

Our expertise is pronounced in obstetrics and gynecology, earning us recognition in fertility solutions. Our scientific pursuits also encompass endocrinology, urology, and andrology, keeping our product range at the forefront of medical innovation.

Our team combines youthful dynamism with a deep commitment to scientific inquiry, a vision set forth and carried on by our founder. This approach guarantees that every product we distribute meets rigorous standards of quality, safety, and efficacy, aligned with our ethical and moral values.

Through global partnerships, we commit to improving healthcare by providing access to our high-quality, effective products.

Everything started with Inofolic^®

Our founder, Prof. Vittorio Unfer, MD is a gynecologist who has always been passionate about scientific research, which led him to study the role of MI in various fields.

Now, he is internationally recognized as the world’s #1 expert in inositol research.

One of the first clinical
trials of myo-inositol in PCOS,
conducted by Lo.Li. Pharma, demonstrated that myo-inositol increases ovulation rates in women suffering from this complex endocrinological condition.

We were the first
to launch a myo-inositol-based product for PCOS, which was a breakthrough in gynecological clinical practice (2009).

Well established, but with consistent year over year market growth, the Inofolic line continues to grow in Italy
and around the world, positively impacting women’s lives over a decade after its launch.

Redefining Modern
Healthcare Solutions

Previous slide

Next slide

Featured Partners

We know your
time is valuable.

Feel free to message our team, and we’ll coordinate a meeting that fits your schedule. We look forward to working with you and helping you achieve your goals.